Table 5: Management options.
| Treatment | Number of patients |
| Bronchodilators | 11 (92%) |
| Inhaled corticosteroids | 10 (83%) |
| Nasal steroids | 6 (50%) |
| Hypertonic saline | 1 (8%) |
| Systemic antibiotics | 5 (42%) |
| Chest physiotherapy | 5 (42%) |
| Lung surgery | 1 (8%) |
| ENT surgery | 10 (83%) |